pharmaphorum2d
Scotland says ‘yes’ to Gilead’s CAR-T Yescarta for lymphoma
Yescarta (axicabtagene ciloleucel) has been approved as a treatment for adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and primary mediastinal large B-cell lymphoma ...
Nature7d
CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to γ-secretase inhibitors
15 Lymphoma cells from a pleural effusion in a pediatric patient with T-cell lymphoblastic disease at relapse were obtained from Morgan Stanley Children's Hospital of New York-Presbyterian ...
Nature5y
Hodgkin lymphoma survivors: high risk of stroke and TIA
A retrospective study of the incidence of these events in a large cohort of Hodgkin lymphoma survivors has now confirmed that patients who received radiation to the neck and mediastinum have a ...
pharmaphorum5y
Real-world data backs Kymriah’s safety profile, says Novartis
The post-marketing studies looked at patients with diffuse large B cell lymphoma (DLBCL) and acute lymphoblastic leukaemia ... s lymphoma called primary mediastinal large B-cell lymphoma (PMBCL ...